Usage
Outcomes achieved using a digital service model for COPD
More than 3 daily patient-reported outcome (PRO) sets were completed per service user per week sustained up to 2 years post onboarding.
Let's look at what that means when considering how Lenus can transform the traditional COPD pathway.
Evidence stats
How the Lenus Service has demonstrated sustained use
-
>50%
RECEIVER participants did not miss a single week of self-reporting at 1 year
-
80%
RECEIVER participants completed 1+ PRO set per week over majority of follow-up
-
3.5
Average daily PRO sets per week in RECEIVER
-
3
Average daily PRO sets per week in Dynamic-Scot
Chart supplement
More information on the data visualised
| N | 225 (at baseline) |
|---|---|
| Inclusion Criteria | RECEIVER and Dynamic-Scot 1 participants. |
| Weekly Interaction Criteria |
Number of weekly interactions was determined by the number of daily CAT entries completed each week. Percentage of service users with each level of interaction was calculated from the service users who were alive and onboarded long enough to complete entries at each weekly timepoint. |
| Data Censoring |
Data for each service user was censored at whichever time period was shortest:
|
- Number of weekly interactions were defined by the number of daily COPD assessment test (CAT) entries that were completed each week.
- The percentage of service users with each level of interaction was calculated at each timepoint from the service users who were alive and onboarded long enough to complete entries during that week.
Study details
ClinicalTrials.gov Identifier: NCT04240353
The feasibility and service adoption observational cohort RECEIVER trial was commenced in September 2019 by NHS Greater Glasgow and Clyde to evaluate the implementation and efficacy of the Lenus COPD Service with high-risk COPD participants matched 1:5 to a control cohort using de-identified contemporary routine clinical data. In March 2021, 'RECEIVER' recruitment was paused and a 'Dynamic-Scot' cohort was established through remote recruitment in the Covid-19 service scale-up to routine care. The protocol is published here with the full results available here.
| Control | RECEIVER | Dynamic-Scot 1 | Service users | |
|---|---|---|---|---|
| Inclusion Criteria |
Selected from the NHS Greater Glasgow and Clyde SafeHaven dataset. Diagnosis of COPD + a COPD-related hospital admission within a 14-day window of a reference RECEIVER trial participant's onboarding date were criteria for entry. From these criteria, the optimal ~5 matches for each RECEIVER participant were determined based on sex and age whilst excluding duplicate control patients or individuals subsequently onboarded to Lenus COPD. |
At least one severe COPD exacerbation in the year prior to onboarding to Lenus COPD and/or chronic hypercapnic respiratory failure/sleep disordered breathing requiring NIV/CPAP treatment. | Onboarded at least 365 days before 31/08/2021 (the data censor date for analyses). | RECEIVER and Dynamic-Scot 1 participants. |
| 1st Participant Index Date | 3rd September 2019 | 3rd September 2019 | 15th May 2020 | 3rd September 2019 |
| Censor Date | 31st August 2021 | |||
| Total Patients | 405 | 83 | 142 | 225 |
NICE advice
Medtech Innovation Briefing
The National Institute of Health and Care Excellence (NICE) has developed a medtech innovation briefing (MIB) on Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease available here.
Get in touch
Got a service in mind for Lenus? Talk to us today.